- A Brief Review of Natural Products with Urate Transporter 1 Inhibition for the Treatment of Hyperuricemia
Qianghua Yuan et al, 2022, Evidence-Based Complementary and Alternative Medicine CrossRef - Sirtuin deficiency and the adverse effects of fructose and uric acid synthesis
Bernardo Rodriguez-Iturbe et al, 2022, American Journal of Physiology-Regulatory, Integrative and Comparative Physiology CrossRef - Resveratrol ameliorates diabetic kidney injury by reducing lipotoxicity and modulates expression of components of the junctional adhesion molecule-like/sirtuin 1 lipid metabolism pathway
Wei Gu et al, 2022, European Journal of Pharmacology CrossRef - Mechanistic insights of soluble uric acid-induced insulin resistance: Insulin signaling and beyond
Wei Yu et al, 2023, Reviews in Endocrine and Metabolic Disorders CrossRef - SLC2A9 rs1014290 Polymorphism is Associated with Prediabetes and Type 2 Diabetes
Xuemei Zhang et al, 2022, International Journal of Endocrinology CrossRef - A review on the fruit components affecting uric acid level and their underlying mechanisms
Fengmao Zou et al, 2021, Journal of Food Biochemistry CrossRef - Effect of Aerobic Treadmill Exercise Regulating Glucose Transporter 9 on Renal Function in Hyperuricemia Rats
Jiarong LIANG et al, 2022, Rehabilitation Medicine CrossRef - Function of Uric Acid Transporters and Their Inhibitors in Hyperuricaemia
Hao-lu Sun et al, 2021, Frontiers in Pharmacology CrossRef - A Randomized Trial on Resveratrol Supplement Affecting Lipid Profile and Other Metabolic Markers in Subjects with Dyslipidemia
Yuqing Zhou et al, 2023, Nutrients CrossRef - Obese female mice do not exhibit overt hyperuricemia despite hepatic steatosis and impaired glucose tolerance
Sara E. Lewis et al, 2022, Advances in Redox Research CrossRef - New insight into the management of renal excretion and hyperuricemia: Potential therapeutic strategies with natural bioactive compounds
Bendong Yang et al, 2022, Frontiers in Pharmacology CrossRef